newsfilter
← Latest News
GlobeNewswire·

argenx to Present at Upcoming Investor Conferences

May 27, 2026Amsterdam, the Netherlands – argenx ((Euronext &, NASDAQ:ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that